Advertisement
UK markets close in 3 hours 5 minutes

  • FTSE 100

    8,337.40
    +23.73 (+0.29%)
     

  • FTSE 250

    20,406.18
    -6.90 (-0.03%)
     

  • AIM

    777.61
    +1.19 (+0.15%)
     

  • GBP/EUR

    1.1616
    -0.0008 (-0.07%)
     

  • GBP/USD

    1.2479
    -0.0031 (-0.25%)
     

  • Bitcoin GBP

    49,949.97
    -1,005.57 (-1.97%)
     

  • CMC Crypto 200

    1,324.10
    +29.43 (+2.27%)
     

  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.42
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,325.10
    +0.90 (+0.04%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,474.94
    +44.89 (+0.24%)
     

  • CAC 40

    8,140.01
    +64.33 (+0.80%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

CORECTED-CVC sells 2.6 pct Evonik stake at 34.60 euros - bookrunner

Reuters - UK Focus

(Corrects to show pricing is 34.60 euros to market not apiece)

LONDON, July 13 (Reuters) - Private Equity firm CVC Capital Partners (Other OTC: PGPHF - news) is selling about 12 million shares in German chemicals group Evonik for 34.60 euros to market, JP Morgan, which is running the sale, said on Monday.

The sale represents about 2.6 percent of Evonik's outstanding shares.

Evonik shares closed down 1 percent at 35.45 euros after regular trading and extended losses in after-trading hours, dropping 2.1 percent to 35.05 euros.

JP Morgan and Banc of America are the joint global coordinators of the placement.

In early-May CVC had already sold a 4.7 percent stake in the chemicals group. (Reporting by Harro ten Wolde; editing by Susan Thomas)